Literature DB >> 11940545

Paradoxical pressor effects of beta-blockers in standing elderly patients with mild hypertension: a beneficial side effect.

T J Cleophas1, I Grabowsky, M G Niemeyer, W M Mäkel, E E van der Wall.   

Abstract

BACKGROUND: Baroreflex sensitivity declines with age, creating a fall in systolic blood pressure and pulse pressure when standing. If, in addition, blood pressure is reduced as a result of antihypertensive medication, compensatory mechanisms may be inadequate and orthostatic problems may occur. This may be less true in patients on beta-blockers. beta-blockers cause pressor effects in standing patients with autonomic neuropathy, but their effects on standing pulse pressures in elderly subjects with mild hypertension have not been systematically studied. METHODS AND
RESULTS: We studied 3741 patients with mild hypertension for 6 months who were being treated with the beta-blocker nebivolol 5 mg daily. Blood pressures were measured after 10 minutes in the supine position and after 1 minute in the standing position. Overall, systolic and diastolic blood pressures rose slightly while standing, whereas pulse pressures remained unchanged. When previously untreated patients (n=2085) >60 and <60 years of age were assessed separately, supine pulse pressures were consistently higher in the elderly group compared with those of the younger subjects by 6 to 11 mm Hg (P<0.001 to 0.0001). However, while standing, pulse pressures rose in the younger subjects, whereas they tended to fall in the elderly group. After 6 months of beta-blockade, this pattern was unchanged in the younger subjects but reversed into significant rise of pulse pressures in the elderly group by 4 (SD 1) mm Hg (P<0.001). In the patients previously treated with other classes of antihypertensive drugs (n=712), the effects were essentially the same.
CONCLUSIONS: In elderly patients with mild hypertension, a depressor trend of pulse pressure while standing can be turned into a significant pressor response by treatment with a beta-blocker.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11940545     DOI: 10.1161/01.cir.0000012745.50229.ac

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  11 in total

Review 1.  Age-related decline in autonomic control of blood pressure: implications for the pharmacological management of hypertension in the elderly.

Authors:  Ton J Cleophas; Rob van Marum
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

2.  Orthostatic hypotension in a cohort of hypertensive patients referring to a hypertension clinic.

Authors:  C Di Stefano; V Milazzo; S Totaro; G Sobrero; A Ravera; A Milan; S Maule; F Veglio
Journal:  J Hum Hypertens       Date:  2015-01-29       Impact factor: 3.012

Review 3.  β-adrenoceptor blockers valuable but higher doses not necessary.

Authors:  Simon B Dimmitt; Hans G Stampfer; John B Warren
Journal:  Br J Clin Pharmacol       Date:  2014-11       Impact factor: 4.335

4.  Orthostatic hypotension as a risk factor for incident heart failure: the atherosclerosis risk in communities study.

Authors:  Christine D Jones; Laura Loehr; Nora Franceschini; Wayne D Rosamond; Patricia P Chang; Eyal Shahar; David J Couper; Kathryn M Rose
Journal:  Hypertension       Date:  2012-03-19       Impact factor: 10.190

Review 5.  Postural blood pressure changes and orthostatic hypotension in the elderly patient: impact of antihypertensive medications.

Authors:  Ihab Hajjar
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 6.  The patient with supine hypertension and orthostatic hypotension: a clinical dilemma.

Authors:  J E Naschitz; G Slobodin; N Elias; I Rosner
Journal:  Postgrad Med J       Date:  2006-04       Impact factor: 2.401

7.  An Emerging Role for Understanding Orthostatic Hyp'er'tension in the Cardiorenal Syndrome.

Authors:  Jaya P Buddineni; Laxmi Chauhan; Syed T Ahsan; Adam Whaley-Connell
Journal:  Cardiorenal Med       Date:  2011-04-15       Impact factor: 2.041

Review 8.  Current pharmacologic treatment for orthostatic hypotension.

Authors:  Roy Freeman
Journal:  Clin Auton Res       Date:  2008-03-27       Impact factor: 4.435

9.  Orthostatic hypertension: From pathophysiology to clinical applications and therapeutic considerations.

Authors:  Nikolaos Magkas; Costas Tsioufis; Costas Thomopoulos; Polychronis Dilaveris; Georgios Georgiopoulos; Michael Doumas; Dimitris Papadopoulos; Dimitrios Tousoulis
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-02-06       Impact factor: 3.738

Review 10.  Yoga for essential hypertension: a systematic review.

Authors:  Jie Wang; Xingjiang Xiong; Wei Liu
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.